BAX and neoplasm: However, evaluating patient response in clinical trials of HSP90 inhibitors in relation to tumor BAX status and also to the mechanism of antitumor activity (apoptosis vs. necrosis) would be required to truly determine the impact of the observations made in this study on the role of BAX in the clinical response to HSP90 inhibition.